Dr Lynne Magor-Blatch, FAPS, FCFP, FCCLP
PhD, M.Clin.Psych; M.Psych (Forensic); B.A. (Hum & Soc.Sci); Grad. Dip. Applied Psych.; Cert IV TAA.
Honorary Principal Fellow, School of Psychology, University of Wollongong
Lynne commenced her training in TCs in the United Kingdom in 1974, working at both Alpha House in Portsmouth and the Ley Community in Oxford. In 1979 she returned to Australia to take up a position with the Victorian Government in Community Education and later, with the Victorian Health Department, working in drug education and prevention at school and community level.
Lynne has more than 40 years’ experience within the Alcohol and Other Drug field, in both the non-government and Government sectors, as a program and clinical director, policy officer, lecturer, researcher and consultant. She has held positions of Associate Professor at the Universities of Canberra, Wollongong and the Australian National University and has extensive experience in program planning and development, particularly in the area of diversion initiatives for offenders and in the establishment of therapeutic community programs for women and families.
Lynne is the primary author of a number of publications, training programs and treatment interventions and has presented at both national and international conferences. She has also served as the National Convener of the Australian Psychological Society’s Psychology and Substance Use Interest Group for a number of years and was the Chair of the Illicit Drugs in Sports Initiative. She has also held appointments to the IGCD National AOD Workforce Development Strategy Working Group, the Advisory Committee for the Review of the Drug and Alcohol Prevention and Treatment Services Sector and is an Associate Editor of the International Journal of Therapeutic Communities.
In 2008, Lynne received the ATCA Award for Significant Contribution to the TC Movement and in 2010, was inducted into the National Drug and Alcohol Awards Honour Roll. In 2013, Lynne completed a PhD with the University of NSW with a study which compared outcomes for 125 participants in five Australian TCs receiving the Group Intervention for Amphetamine-type Stimulant (ATS) use (GIATS) with treatment as usual for 121 participants in seven matched TCs. In 2016, she was one of eleven people chosen from across the world to represent Civil Society in New York at the United Nations General Assembly Special Sitting (UNGASS) on the world drug problem.